-
International Journal of Women's Health
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Estrogens of multiple classes and their role in mental health disease mechanisms
Review
(1933) Views (642) Full article downloads
Authors: Cheryl S Watson, Rebecca A Alyea, Kathryn A Cunningham, et al
Published Date June 2010
Volume 2010:2 Pages 153 - 166
DOI: http://dx.doi.org/10.2147/IJWH.S6907
Cheryl S Watson1, Rebecca A Alyea1, Kathryn A Cunningham2, Yow-Jiun Jeng1
1Department of Biochemistry and Molecular Biology, 2Department of Pharmacology and Toxicology, Univ of Texas Medical Branch, Galveston, TX, USA
Abstract: Gender and sex hormones can influence a variety of mental health states, including mood, cognitive development and function, and vulnerability to neurodegenerative diseases and brain damage. Functions of neuronal cells may be altered by estrogens depending upon the availability of different physiological estrogenic ligands; these ligands and their effects vary with life stages, the genetic or postgenetic regulation of receptor levels in specific tissues, or the intercession of competing nonphysiological ligands (either intentional or unintentional, beneficial to health or not). Here we review evidence for how different estrogens (physiological and environmental/dietary), acting via different estrogen receptor subtypes residing in alternative subcellular locations, influence brain functions and behavior. We also discuss the families of receptors and transporters for monoamine neurotransmitters and how they may interact with the estrogenic signaling pathways.
Keywords: estrogen receptor α, estrogen receptor β, GPR30, GPER, xenoestrogens, phytoestrogens, transporters, brain function, neurotransmitter receptors
Readers of this article also read:
Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions
Optimal management of perimenopausal depression
Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device
Management of hypoactive sexual desire disorder in women: current and emerging therapies
Cervical cancer screening: knowledge, health perception and attendance rate among Hong Kong Chinese women
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
Zinc oxide nanoparticles as selective killers of proliferating cells
Estradiol valerate and dienogest: a new approach to oral contraception
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions
- Tinidazole in the treatment of bacterial vaginosis
- Diagnosis and management of pre-eclampsia: an update
- Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy




